We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

73 hedge funds and large institutions have $285M invested in GenMark Diagnostics, Inc in 2013 Q2 according to their latest regulatory filings, with 73 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less call options, than puts

Call options by funds: $321K | Put options by funds: $363K

Holders
73
Holders Change
+73
Holders Change %
–
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
73
Increased
–
Reduced
–
Closed
–
Calls
$321K
Puts
$363K
Net Calls
-$42K
Net Calls Change
-$42K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.8M +$67.8M +4,915,558 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$40.3M +$53.7M +3,893,700 New
Jennison Associates
3
Jennison Associates
New York
$38.1M +$50.8M +3,680,723 New
Artisan Partners
4
Artisan Partners
Wisconsin
$19.8M +$26.4M +1,913,790 New
PI
5
Putnam Investments
Massachusetts
$18M +$24.1M +1,745,494 New
Massachusetts Financial Services
6
Massachusetts Financial Services
Massachusetts
$12.4M +$16.6M +1,201,380 New
CCM
7
Camber Capital Management
Massachusetts
$9.82M +$13.1M +950,000 New
CRC
8
Curi RMB Capital
Illinois
$9.72M +$13M +939,265 New
Bank of America
9
Bank of America
North Carolina
$8.7M +$11.6M +840,868 New
BFA
10
BlackRock Fund Advisors
California
$7.56M +$10.1M +730,701 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$7.48M +$9.97M +723,156 New
BA
12
BlackRock Advisors
Delaware
$6.46M +$8.61M +624,510 New
PHS
13
PFM Health Sciences
California
$6.25M +$8.33M +604,199 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$6.22M +$8.29M +601,028 New
JP Morgan Chase
15
JP Morgan Chase
New York
$3.7M +$4.92M +357,155 New
BIT
16
BlackRock Institutional Trust
California
$3.27M +$4.36M +315,909 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$3.25M +$4.34M +314,502 New
State Street
18
State Street
Massachusetts
$3.21M +$4.28M +310,400 New
PC
19
PointState Capital
New York
$3.09M +$4.12M +298,976 New
Allianz Asset Management
20
Allianz Asset Management
Germany
$2.33M +$3.1M +224,799 New
CCI
21
Columbus Circle Investors
$1.65M +$2.19M +159,065 New
Deutsche Bank
22
Deutsche Bank
Germany
$1.52M +$2.03M +146,866 New
Northern Trust
23
Northern Trust
Illinois
$1.48M +$1.97M +143,069 New
TCIM
24
TIAA CREF Investment Management
New York
$1.23M +$1.64M +118,835 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$1.23M +$1.63M +118,434 New
1
2 3

GNMK Hedge Fund Activity: Q2 2013 in Review

73 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2013, worth a combined $285M.

Buyers outnumbered sellers: 73 funds opened new GNMK positions and 0 closed out — a net gain of 73 holders — while 0 added to existing stakes and 0 trimmed.

  • 73 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $285M of GenMark Diagnostics, Inc stock for Q2 2013.
  • 73 funds opened new GenMark Diagnostics, Inc positions in Q2 2013 and 0 closed out, a net change of +73 holders.

Based on aggregated 13F filings for Q2 2013.